Joint Meeting of the
ADVISORY COMMITTEE FOR PHARMACEUTICAL SCIENCE AND
THE DERMATOLOGIC AND OPHTHALMIC DRUGS ADVISORY COMMITTEE
November 17, 2000
Federal Register Notice – November 17, 2000 Meeting pdf htm
FDA Background Information pdf doc
Draft Guidance for Industry: Topical Dermatological Drug Product NDAs and ANDAs -- In Vivo Bioavailability, Bioequivalence, In Vitro Release, and Associated Studies, June 1998